Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 9,787	$ (2,199)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock based compensation	4,047	2,889
Amortization of debt issuance costs and discounts	93	87
Provision for expected losses	3,423	1,823
Provision for inventory reserve	92	25
Depreciation and amortization included in operating expenses	7,976	5,029
Depreciation included in cost of subscription and transaction fees for rental equipment	1,137	852
Non-cash lease expense	1,070	(429)
Deferred income taxes	134	72
Other	527	363
Changes in operating assets and liabilities:
Accounts receivable	(16,471)	9,589
Finance receivables	3,038	(653)
Inventory	(5,584)	(8,245)
Prepaid expenses and other assets	(3,762)	(746)
Accounts payable and accrued expenses	8,455	(2,868)
Operating lease liabilities	(655)	183
Deferred revenue	174	1
Net cash provided by operating activities	13,481	5,773
Cash flows from investing activities:
Acquisition of business, net of cash acquired	(4,750)	(35,855)
Capital expenditures	(9,175)	(12,634)
Net cash used in investing activities	(13,925)	(48,489)
Cash flows from financing activities:
Proceeds from long-term debt	0	25,000
Repayment of long-term debt	(389)	(580)
Contingent consideration paid for acquisition	0	(1,000)
Proceeds from exercise of common stock options	96	0
Repurchase of Series A Convertible Preferred Stock	0	(2,153)
Net cash (used in) provided by financing activities	(293)	21,267
Effect of currency exchange rate changes on cash and cash equivalents	7	0
Net decrease in cash and cash equivalents	(730)	(21,449)
Cash and cash equivalents at beginning of year	50,927	68,125
Cash and cash equivalents at end of period	50,197	46,676
Supplemental disclosures of cash flow information:
Interest paid in cash	2,628	1,869
Income taxes paid in cash	142	44
Common stock issued in business combination	$ 0	$ 3,942